Important Clarification: Question Mismatch
There appears to be a critical error in this question. The user is asking about Jelmyto (mitomycin gel for pyelocalyceal instillation), but the expanded context and all provided evidence discuss belzutifan (Welireg), which is a completely different medication for VHL disease and renal cell carcinoma.
If the Question is About Jelmyto (Mitomycin):
Fever management with Jelmyto is not specifically addressed in the FDA label, so treat fever as you would any post-procedural fever following urologic instrumentation 1.
Approach to Fever with Jelmyto:
- Rule out infectious causes first: Jelmyto is instilled via ureteral catheter or nephrostomy tube, creating risk for urinary tract infection or pyelonephritis
- Consider drug fever: Onset typically 7-10 days after drug administration in nonsensitized individuals 2
- Symptomatic management: Antipyretics can be used for patient comfort, though routine fever suppression remains controversial 3
- If infection is ruled out and drug fever suspected: Consider withholding next Jelmyto instillation and monitoring for fever resolution
Key Jelmyto-Specific Considerations:
- Prophylactic antibiotics may be used at the discretion of the treating urologist 1
- The FDA label does not list fever as a common adverse event
- Jelmyto is administered weekly for 6 weeks, then monthly if complete response achieved 1
If the Question is Actually About Belzutifan (Welireg):
Fever is not listed among the common adverse events with belzutifan; the primary toxicities are anemia, hypoxia, fatigue, nausea, and hypertension 4.
Management Approach:
- Investigate other causes: Fever is not a recognized belzutifan toxicity, so pursue standard infectious and non-infectious workup
- Continue belzutifan unless grade 3+ adverse event: The drug should only be withheld for grade 3 adverse events until improvement to grade 2, then resume with 40 mg dose reduction if necessary 4
- Monitor for actual belzutifan toxicities: Check CBC monthly for anemia (most common serious toxicity at 29% grade 3-4) 4
Please clarify which medication you are asking about, as the management differs entirely.